Zafar Hakim

666 total citations
15 papers, 555 citations indexed

About

Zafar Hakim is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Hepatology. According to data from OpenAlex, Zafar Hakim has authored 15 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Hepatology. Recurrent topics in Zafar Hakim's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Hepatitis C virus research (3 papers) and Acute Myocardial Infarction Research (2 papers). Zafar Hakim is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Hepatitis C virus research (3 papers) and Acute Myocardial Infarction Research (2 papers). Zafar Hakim collaborates with scholars based in United States, Switzerland and Australia. Zafar Hakim's co-authors include Emily Beth Devine, Dev S. Pathak, Jesse Green, Leah Kleinman, Dennis A. Revicki, Lauren Krupp, Kelvin Chan, Marc W. Zodet, Eric L. Eisenstein and Anne Wolf and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Medical Care.

In The Last Decade

Zafar Hakim

14 papers receiving 508 citations

Peers

Zafar Hakim

EE

PMH

EPIDE

ECP

CCM

Ruth Navarro‐Artieda Spain

Gianluigi Balestroni Italy

Jan-Samuel Wagner United States

Steve Fullerton United States

Montse Roset Spain

Ahmed Negm Canada

Reto Kofmehl Switzerland

Kristin Delaney United States

Lisha Hou China

William Molloy Ireland

Ruth Navarro‐Artieda Spain

Zafar Hakim

161 ×1.3

EE

187 ×2.2

PMH

169 ×2.1

EPIDE

46 ×0.6

ECP

81 ×1.1

CCM

Citations per year, relative to Zafar Hakim Zafar Hakim (= 1×) peers Ruth Navarro‐Artieda

Countries citing papers authored by Zafar Hakim

Since Specialization

Citations

This map shows the geographic impact of Zafar Hakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafar Hakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafar Hakim more than expected).

Fields of papers citing papers by Zafar Hakim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafar Hakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafar Hakim. The network helps show where Zafar Hakim may publish in the future.

Co-authorship network of co-authors of Zafar Hakim

This figure shows the co-authorship network connecting the top 25 collaborators of Zafar Hakim. A scholar is included among the top collaborators of Zafar Hakim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafar Hakim. Zafar Hakim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Devine, Emily Beth, Zafar Hakim, & Jesse Green. (2005). A Systematic Review of Patient-Reported Outcome Instruments Measuring Sleep Dysfunction in Adults. PharmacoEconomics. 23(9). 889–912. 84 indexed citations

2.

Eisenstein, Eric L., Linda K. Shaw, Charlotte Nelson, et al.. (2002). Obesity and Long‐Term Clinical and Economic Outcomes in Coronary Artery Disease Patients. Obesity Research. 10(2). 83–91. 45 indexed citations

3.

Hakim, Zafar, Anne Wolf, & Louis P. Garrison. (2002). Estimating the Effect of Changes in Body Mass Index on Health State Preferences. PharmacoEconomics. 20(6). 393–404. 53 indexed citations

4.

Sullivan, Sean D., et al.. (2002). Health State Preference Assessment in Diabetic Peripheral Neuropathy. PharmacoEconomics. 20(15). 1079–1089. 24 indexed citations

5.

Eisenstein, Eric L., Linda K. Shaw, Kevin J. Anstrom, et al.. (2001). Assessing the Clinical and Economic Burden of Coronary Artery Disease: 1986-1998. Medical Care. 39(8). 824–835. 73 indexed citations

6.

Kleinman, Leah, Marc W. Zodet, Zafar Hakim, et al.. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research. 9(5). 499–508. 154 indexed citations

7.

Kleinman, Leah, et al.. (2000). Reliability, validity, and scaling of fatigue severity scales for patients with chronic hepatitis C. Journal of Hepatology. 32. 186–186. 4 indexed citations

8.

Cooksley, Graham, Graham R. Foster, Jesse Green, et al.. (2000). The effect of successful anti-viral therapy on health-related quality of life for patients with chronic hepatitis C and cirrhosis. Gastroenterology. 118(4). A951–A951. 6 indexed citations

9.

Hakim, Zafar & Dev S. Pathak. (1999). Modelling the EuroQol data: a comparison of discrete choice conjoint and conditional preference modelling. Health Economics. 8(2). 103–116. 56 indexed citations

10.

Hakim, Zafar, et al.. (1999). The Economics of Multiple Sclerosis. PharmacoEconomics. 15(3). 229–240. 36 indexed citations

11.

Hakim, Zafar, et al.. (1999). TPRD7: ESTIMATING LIFE-EXPECTANCY IN POSTACUTE CORONARY SYNDROMES: THE IMPORTANCE OF TWO-COMPONENT SURVIVAL MODELS. Value in Health. 2(3). 160–161. 1 indexed citations

12.

Hakim, Zafar & Dev S. Pathak. (1999). Modelling the EuroQol data: a comparison of discrete choice conjoint and conditional preference modelling. Health Economics. 8(2). 103–116. 4 indexed citations

13.

Hakim, Zafar, et al.. (1998). Use of the QOLIE-31 in Routine Clinical Practice. Journal of Epilepsy. 11(1). 34–47. 12 indexed citations

14.

Hakim, Zafar & Suzan N. Kucukarslan. (1993). Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.. PubMed. 15(2). 442–58; discussion 432.

15.

Kucukarslan, Suzan N., et al.. (1993). Points to consider about prescription drug prices: an overview of federal policy and pricing studies.. PubMed. 15(4). 726–38. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact